Melanocortin-4 receptor gene and physical activity in the Québec Family Study

International Journal of Obesity

Volumn 29, Issue 4, 2005, Pages 420-428

  Loos, R J F ^a   Rankinen, T ^a   Tremblay, A ^b   Perusse L ^b   Chagnon, Y ^c   Bouchard, C ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b UNIVERSITÉ LAVAL   (Canada)

^c CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

Author keywords

Candidate genes; Genetic polymorphisms; Neuropeptides; Sedentary

Indexed keywords

AGOUTI RELATED PROTEIN; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; HORMONE RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; PROOPIOMELANOCORTIN;

ADULT; ARCUATE NUCLEUS; ARTICLE; BODY MASS; CANADA; CHRONIC DISEASE; DNA SEQUENCE; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS; MALE; PHENOTYPE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGENY; RECEPTOR GENE; RISK FACTOR; SITTING; THALAMUS MIDLINE NUCLEUS;

CHI-SQUARE DISTRIBUTION; EXERCISE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; QUEBEC; RECEPTOR, MELANOCORTIN, TYPE 4;

AGOUTI;

EID: 16244409491     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802869     Document Type: Article

References (49)

1. Booth FW, Chakravarthy MV, Gordon SE, Spangenburg EE. Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy. J Appl Physiol 2002; 93: 3-30.
2. Center for Disease Control and Prevention. Surgeon General's report on physical activity and health. JAMA 1996; 276: 522.
3. van der Bij AK, Laurant MG, Wensing M. Effectiveness of physical activity interventions for older adults: a review. Am J Prev Med 2002; 22: 120-133.
4. Beunen G, Thomis M, Loos R, Maes H, Derom C, Vlietinck R. Genetic determinants of sport activities. Pediatr Exerc Sci 1999; 11: 278.
5. Parusse L, Tremblay A, Leblanc C, Bouchard C. Genetic and environmental influences on level of habitual physical activity and exercise participation. Am J Epidemiol 1989; 129: 1012-1022.
6. Simonen RL, Perusse L, Rankinen T, Rice T, Rao DC, Bouchard C. Familial aggregation of physical activity levels in the Quebec Family Study. Med Sci Sports Exerc 2002; 34: 1137-1142.
7. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 1995; 332: 621-628.
8. Levine JA, Eberhardt NL, Jensen MD. Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science 1999; 283: 212-214.
9. Bouchard C, Tremblay A, Despres JP, Nadeau A, Lupien PJ, Theriault G, Dussault J, Moorjani S, Pinault S, Fournier G. The response to long-term overfeeding in identical twins. N Engl J Med 1990; 322: 1477-1482.
10. Tremblay A, Despres JP, Thériault G, Fournier G, Bouchard C. Overfeeding and energy expenditure in humans. Am J Clin Nutr 1992; 56: 857-862.
11. Klingberg F, Klengel S. Lesions in four parts of the basal forebrain change basic behaviour in rats. Neuroreport 1993; 4: 639-642.
12. Tokunaga K, Matsuzawa Y, Fujioka S, Kobatake T, Keno Y, Odaka H, Matsuo T, Tarui S. PVN-lesioned obese rats maintain ambulatory activity and its circadian rhythm. Brain Res Bull 1991; 26: 393-396.
13. Zhuo QY, Palmiter RD. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 1995; 83: 1197-1209.
14. Ste Marie L, Miura GI, Marsh DJ, Yagaloff K, Palmiter RD. A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc Natl Acad Sci USA 2000; 97: 12339-12344.
15. Butler AA, Marks DL, Fan W, Kuhn CM, Bartolome M, Cone RD. Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat. Nat Neurosci 2001; 4: 605-611.
16. Butler AA, Kesterson RA, Khong K, Cullen MJ, Pelleymounter MA, Dekoning J, Baetscher M, Cone RD. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 2000; 141: 3518-3521.
17. Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan X-M, Yu H, Rosenblum CI, Vongs A, Feng Y, Cao L, Metzger JM, Strack AM, Camacho RE, Mellin TN, Nunes CN, Min W, Fisher J, Gopal-Truter S, MacIntyre DE, Chen HY, Van der Ploeg LHT. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 2000; 26: 97-102.
18. Kimmel HL, Thim L, Kuhar MJ. Activity of various CART peptides in changing locomotor activity in the rat. Neuropeptides 2002; 36: 9-12.
19. Bouchard C. Genetic epidemiology, association, and sib-pair linkage: results from the Québec Family Study. In: Bray GA, Ryan DH (eds). Molecular and genetic aspects of obesity. Louisiana State University: Baton Rouge, LA; 1996. pp 470-481.
20. Bouchard C, Tremblay A, Leblanc C, Lortie G, Savard R, Thériault G. A method to assess energy expenditure in children and adults. Am J Clin Nutr 1983; 37: 461-467.
21. Chagnon YC, Chen WJ, Perusse L, Chagnon M, Nadeau A, Wilkison WO, Bouchard C. Linkage and association studies between the melanocortin receptors 4 and 5 genes and obesity-related phenotypes in the Quebec Family Study. Mol Med 1997; 3: 663-673.
22. Gotoda T, Scott J, Aitman TJ. Molecular screening of the human melanocortin-4 receptor gene: identification of a missense variant showing no association with obesity, plasma glucose, or insulin. Diabetologia 1997; 40: 976-979.
23. Boucher N, Lanouette CM, Larose M, Perusse L, Bouchard C, Chagnon YC. A +2138InsCAGACC polymorphism of the melanocortin receptor 3 gene is associated in human with fat level and partitioning in interaction with body corpulence. Mol Med 2002; 8: 158-165.
24. Grabe N. AliBaba2: context specific identification of transcription factor binding sites. In Silico Biol 2002; 2: S1-S15.
25. Petsko G. Modeling structure from sequence. In: Baxevanis AD (ed). Current protocols in bioinformatics. Wiley: Indianapolis, IN; 2002.
26. Chagnon YC, Borecki IB, Perusse L, Roy S, Lacaille M, Chagnon M, Ho-Kim MA, Rice T, Province MA, Rao DC, Bouchard C. Genome-wide search for genes to the fat-free body mass in the Quebec Family Study. Metabolism 2000; 49: 203-207.
27. Cummings DE, Schwartz MW. Melanocortins and body weight: a tale of two receptors. Nat Genet 2000; 26: 8-9.
28. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997; 88: 131-141.
29. Yeo GSH, Farooqi IS, Aminian S, Halsall D, Stanhope RG, O'Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 1998; 20: 111-112.
30. Vaisse C, Clement K, Guy-Grand B, Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 1998; 20: 113-114.
31. Sina M, Hinney A, Ziegler A, Neupert T, Mayer H, Siegfried W, Blum WF, Remschmidt H, Hebebrand J. Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene. Am J Hum Genet 1999; 65: 1501-1507.
32. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 2000; 106: 253-262.
33. Gu W, Tu Z, Kleyn PW, Kissebah A, Duprat L, Lee J, Chin W, Maruti S, Deng N, Fisher SL, Franco LS, Burn P, Yagaloff KA, Nathan J, Heymsfield S, Albu J, Pi-Sunyer FX, Allison DB. Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes 1999; 48: 635-639.
34. Farooqi IS, Yeo GSH, Keogh JM, Aminian S, Jebb SA, Butler G, Cheetham T, O'Rahilly S. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000; 106: 271-279.
35. Mergen M, Mergen H, Ozata M, Oner R, Oner C. Rapid communication: a novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity. J Clin Endocrinol Metab 2001; 86: 3448.
36. Hinney A, Schmidt A, Nottebom K, Heibult O, Becker I, Ziegler A, Gerber G, Sina M, Gorg T, Mayer H, Siegfried W, Fichter M, Remschmidt H, Hebebrand J. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab 1999; 84: 1483-1486.
37. Dubern B, Clement K, Pelloux V, Froguel P, Girardet JP, Guy-Grand B, Tounian P. Mutational analysis of melanocortin-4 receptor, agouti-related protein, and alpha-melanocyte-stimulating hormone genes in severely obese children. J Pediatr 2001; 139: 204-209.
38. Kobayashi H, Ogawa Y, Shintani M, Ebihara K, Shimodahira M, Iwakura T, Hino M, Ishihara T, Ikekubo K, Kurahachi H, Nakao K. A novel homozygous missense mutation of melanocortin-4 receptor (MC4R) in a Japanese woman with severe obesity. Diabetes 2002; 51: 243-246.
39. Jacobson P, Ukkola O, Rankinen T, Snyder EE, Leon AS, Rao DC, Skinner JS, Wilmore JH, Lonn L, Cowan Jr GS, Sjostrom L, Bouchard C. Melanocortin 4 receptor sequence variations are seldom a cause of human obesity: the Swedish obese subjects, the HERITAGE Family Study, and a Memphis cohort. J Clin Endocrinol Metab 2002; 87: 4442-4446.
40. Miraglia del Giudice E, Cirillo G, Nigro V, Santoro N, D'Urso L, Raimondo P, Cozzolino D, Scafato D, Perrone L. Low frequency of melanocortin-4 receptor (MC4R) mutations in a Mediterranean population with early-onset obesity. Int J Obes Relat Metab Disord 2002; 26: 647-651.
41. Marti A, Corbalan MS, Forga L, Martinez JA, Hinney A, Hebebrand J. A novel nonsense mutation in the melanocortin-4 receptor associated with obesity in a Spanish population. Int J Obes Relat Metab Disord 2003; 27: 385-388.
42. Farooqi IS, Keogh JM, Yeo GSH, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003; 348: 1085-1095.
43. Branson R, Potoczna N, Kral JG, Lentes KU, Hoehe MR, Horber FF. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003; 348: 1096-1103.
44. Ho G, MacKenzie RG. Functional characterization of mutations in melanocortin-4 receptor associated with human obesity. J Biol Chem 1999; 274: 35816-35822.
45. Yeo GSH, Lank EJ, Farooqi IF, Keogh JM, Challis BG, O'Rahilly S. Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms. Hum Mol Genet 2003; 12: 561-574.
46. Adage T, Scheurink AJW, de Boer SF, de Vries K, Konsman JP, Kuipers F, Adan RAH, Baskin DG, Schwartz MW, van Dijk G. Hypothalamic, metabolic, and behavioral responses to pharmacological inhibition of CNS melanocortin signaling in rats. J Neurosci 2001; 21: 3639-3645.
47. Salbe AD, Weyer C, Harper I, Lindsay RS, Ravussin E, Tataranni PA. Assessing risk factors for obesity between childhood and adolescence: ii. Energy metabolism and physical activity. Pediatrics 2002; 110: 307-314.
48. Gortmaker SL, Dietz WH, Cheung LW. Inactivity, diet, and the fattening of America. J Am Diet Assoc 1990; 90: 1247-1252.
49. Rohner-Jeanrenaud F, Craft LS, Bridwell J, Sutter TM, Tinsley FC, Smiley DL, Burkhart DR, Statnick MA, Heiman ML, Ravussin E, Caro JF. Chronic central infusion of cocaine- and amphetamine-regulated transcript (CART 55-102): effects on body weight homeostasis in lean and high-fat-fed obese rats. Int J Obes Relat Metab Disord 2002; 26: 143-149.